Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the debt to assets ratio high or low?
The debt to assets ratio of 101.47% is 184% above its 5-year average of 35.70%, near the high end of its 5-year range (0.52%–101.47%).
As of the fiscal period ended Tuesday, June 30, 2026. 19.82% above its 12-month average of 84.69%.
Reported quarterly debt to assets ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 101.47%.
DEBT TO ASSETS RATIO
101.47%
DEBT TO ASSETS RATIO AVG TTM
84.69%
DEBT TO ASSETS RATIO AVG 3Y
57.03%
DEBT TO ASSETS RATIO AVG 5Y
35.70%
DEBT TO ASSETS RATIO AVG 10Y
19.51%
DEBT TO ASSETS RATIO AVG 15Y
0.53%
DEBT TO ASSETS RATIO AVG 20Y
0.52%
CURRENT VS TTM AVG
+19.82%
CURRENT VS 3Y AVG
+77.92%
CURRENT VS 5Y AVG
+184.24%
CURRENT VS 10Y AVG
+420.07%
CURRENT VS 15Y AVG
+19054.58%
CURRENT VS 20Y AVG
+19519.74%
SECTOR MEDIAN · HEALTHCARE
0.09%
median of 873 covered companies
CURRENT VS SECTOR MEDIAN
+112648.35%
vs the sector median at left
Avita Medical Inc.
Market Cap
$322.71M
Debt to Assets Ratio
101.47%
TTM Avg
84.69%
3Y Avg
57.03%
5Y Avg
35.70%
Market Cap
$321.76M
Debt to Assets Ratio
0.70%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$318.43M
Debt to Assets Ratio
0.16%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$329.37M
Debt to Assets Ratio
0.10%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$330.19M
Debt to Assets Ratio
0.74%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$309.19M
Debt to Assets Ratio
0.00%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$344.04M
Debt to Assets Ratio
0.00%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | DEBT TO ASSETS RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Avita Medical Inc. (RCEL) | $322.71M | 101.47% | 84.69% | 57.03% | 35.70% |
| Sanara MedTech Inc. (SMTI)vs › | $321.76M | 0.70% | N/A | N/A | N/A |
| CapsoVision, Inc. (CV)vs › | $324.76M | 0.04% | N/A | N/A | N/A |
| C4 Therapeutics, Inc. (CCCC)vs › | $318.43M | 0.16% | N/A | N/A | N/A |
| Cabaletta Bio, Inc. (CABA)vs › | $329.37M | 0.10% | N/A | N/A | N/A |
| ClearPoint Neuro, Inc. (CLPT)vs › | $330.19M | 0.74% | N/A | N/A | N/A |
| Agenus Inc. (AGEN)vs › | $311.90M | 0.24% | N/A | N/A | N/A |
| Benitec Biopharma Inc. (BNTC)vs › | $309.19M | 0.00% | N/A | N/A | N/A |
| Relmada Therapeutics, Inc. (RLMD)vs › | $344.04M | 0.00% | N/A | N/A | N/A |
| Turn Therapeutics Inc. (TTRX)vs › | $346.73M | 0.36% | N/A | N/A | N/A |
Debt/Assets
101.5%
Debt/Equity
N/A
Current Ratio
0.41
Interest Coverage
-8.5x
Formula: Debt/Assets = Total Debt / Total Assets × 100
Debt/Assets vs Debt/Equity:
Industry context matters: Capital-intensive industries (utilities, real estate) typically have higher Debt/Assets ratios than tech companies.
Debt/Assets ratio shows what percentage of a company's assets are financed by debt. Compare the current value with the historical chart and peer group to understand leverage over time.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | DEBT TO ASSETS RATIO |
|---|---|
| 2026-06-30 | 101.47% |
| 2026-03-31 | 93.36% |
| 2025-12-31 | 81.66% |
| 2025-09-30 | 70.26% |
| 2025-06-30 | 76.70% |
| 2025-03-31 | 63.36% |
| 2024-12-31 | 57.69% |
| 2024-09-30 | 56.29% |
| 2024-06-30 | 51.34% |
| 2024-03-31 | 45.94% |
| 2023-12-31 | 37.99% |
| 2023-09-30 | 3.39% |
| 2023-06-30 | 1.97% |
| 2023-03-31 | 2.02% |
| 2022-12-31 | 0.93% |
| 2022-09-30 | 1.11% |
| 2022-06-30 | 0.52% |
| 2022-03-31 | 0.68% |
| 2021-12-31 | 1.41% |
| 2021-09-30 | 0.91% |
| 2021-06-30 | 0.70% |
| 2021-03-31 | 0.83% |
| 2020-12-31 | 1.79% |
| 2020-09-30 | 2.35% |
| 2020-06-30 | 2.32% |
| 2019-12-31 | 2.32% |
| 2019-06-30 | 0.00% |
| 2019-03-31 | 0.00% |
| 2018-12-31 | 0.23% |
| 2018-09-30 | 0.23% |
| 2018-06-30 | 0.58% |
| 2018-03-31 | 0.58% |
| 2017-12-31 | 0.00% |
| 2017-09-30 | 0.00% |
| 2017-06-30 | 0.00% |
| 2017-03-31 | 0.00% |
| 2016-12-31 | 0.00% |
| 2016-09-30 | 0.00% |
| 2016-06-30 | 0.00% |
| 2016-03-31 | 0.00% |
| 2015-12-31 | 0.00% |
| 2015-09-30 | 0.00% |
| 2015-06-30 | 0.00% |
| 2015-03-31 | 0.00% |
| 2014-12-31 | 0.00% |
| 2014-09-30 | 0.00% |
| 2014-06-30 | 0.00% |
| 2014-03-31 | 0.00% |
| 2013-12-31 | 0.00% |
| 2013-09-30 | 0.00% |
| 2013-06-30 | 0.00% |
| 2013-03-31 | 0.00% |
| 2012-12-31 | 0.00% |
| 2012-09-30 | 0.00% |
| 2012-06-30 | 0.00% |
| 2012-03-31 | 0.00% |
| 2011-12-31 | 0.00% |
| 2011-06-30 | 0.00% |
| 2010-12-31 | 0.00% |
| 2010-06-30 | 0.00% |
| 2009-12-31 | 0.00% |
| 2009-06-30 | 0.00% |
| 2008-12-31 | 1.56% |
| 2008-06-30 | 3.02% |
| 2007-12-31 | 0.00% |
| 2007-06-30 | 0.00% |
| 2006-12-31 | 0.00% |
| 2006-06-30 | 0.00% |
| 2005-12-31 | 0.03% |
| 2004-12-31 | 0.05% |
| 2004-06-30 | 0.11% |
| 2003-12-31 | 0.10% |
| 2002-12-31 | 1.30% |
| 2001-12-31 | 0.81% |
| 2000-12-31 | 0.00% |
| 1999-12-31 | 0.00% |
| 1998-12-31 | 0.00% |
| 1997-12-31 | 0.00% |
